FDA bars own expert from evaluating risks of painkillers
AUTOR(ES)
Lenzer, Jeanne
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=529357Documentos Relacionados
- FDA warns of risks from breast implants
- FDA hearings confirm risks of antidepressants
- FDA to review risks of antidepressants in adults
- Evaluating the clinical appropriateness of nurses' prescribing practice: method development and findings from an expert panel analysis
- Evaluating the risks of therapies for acute coronary syndromes